@patientinvestor patientinvestor

Grade = how their written analysis reads (A best). Trader score = how their last-20 timestamped calls performed vs SPY. · Analyst brief as of 2026-06-22.

patientinvestor is mostly surfacing valuation screens rather than explicit trades: Mag 7 growth expectations, quality names near lows, below-PEG growth stocks, and sub-10x earnings names. The distinctive read is a contrarian quality/value scan across large-cap tech, payments, software, and select growth names, with Netflix singled out as becoming interesting at 23x earnings. There are no position disclosures or directional trade calls in the payload, so conviction is best read as consistent screening activity rather than proven adding, trimming, or flipping.

The author is concentrated in valuation-screening work: Mag 7 growth expectations, quality names near lows, below-PEG growth, and sub-10x earnings lists. There are no CALL_DIRECTIONAL or POSITION_DISCLOSURE signals, so no objective adds, trims, exits, or flips can be inferred from the payload. Concentration risk is modest, with repeated attention to META, MSFT, MA, and ADBE but mostly as screens rather than disclosed trades.

Grade is our human read-worthiness rating; trader score is a rolling 20-bet hit-rate/alpha composite — different things, often disagreeing. “Since then” is direction-unaware in the table; the summary line above adjusts for which way they leaned.